PROGRAM 

Moderator: Patrick Tricoli, Senior Director,

Partnering & Innovation, sanofi-aventis

 

 

2:30 pm Registration open

 

3:00 pm Welcome Address
> His excellency Pierre Vimont, Ambassador of France in United States

The honorable Philippe Larrieu, Consul General of France in Los Angeles

3:20 pm  Opening
=> What are the Key Success Factors for Biotechnology and a Key Player like Amgen to Develop in France ?
> Marc de GARIDEL, VP South Region International Commercial Operations, AMGEN

 

3:40 pm 

=> How Relevant is it on Gathering Partnerships and Building a Biocluster Critical Mass?
> Experience the Following Developments

• PHENOPRO:  From Academic Phenotyping Spinout to International Industrial Partnership
  Frédéric Allemand, MD, Head of Operations and Corporate Development, PhenoPro SAS
  San Phelan, Chairman, Taconic Farms

 

• EBx®: a New Cell Platform for the Biomanufacturing of Monoclonal Antibodies
  Dr Pierre Miniou, Licensing & Business Development, Vivalis 

 

• MEDUL:  New Hope for Spinal Cord Injury Patients
  Pascal Deschaseaux, MD, MBA, CEO, Pharmaxon

 

• IgA: an Investigation in the Therapeutic Potential of Monoclonal IgA
  Eric Perouzel, Business Development Manager, InvivoGen Therapeutics

 

• DEMINAP: Use of Toll-like Receptors to Detect Unapparent Micro-Organisms for Diagnostic and Therapeutic Applications
  Yannis Morel, Director, Business Development, Innate Pharma

 

• PREDICAN : An Innovative Screening Method for Mutations Detection 
  Nicolas Guyot, CEO, FLUIGENT 

 

• IT-Diab : Innovative Therapy - Diabetes   
  Jean François MOUNEY, Chairman and CEO, GENFIT

5:30 to 6:00 pm 
Key Note : American Companies from San Diego supporting French BIO Beach
> Introduction by Stephane Richard, Staff Scientist at the Salk Institute for Biological Studies, Founder of  Gen2X and French BIO Beach

>Claude Benchimol, Senior Vice-President, Research & Development, INVITROGEN Corporation 

>Alan Carter, Senior Vice-President, Business Development, CODA Genomics

6:00 to 6:30 pm  Closing
How does a Global Pharmaceutical Industry Develop their Partnerships with France?
=> The point of view of sanofi pasteur
Luc Aujame, Director, External R&D, sanofi pasteur   

6:30 to 7:15 pm Speedy Networking and Meeting Corner
=> To meet potential partners and exchange with major biotech business actors

07:30 to 9:00 pm  The Big Party
=>To continue your networking

 

* to be confirmed